Survivorship: Effects of Cancer Treatment on Long-Term Morbidity

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In Chapter 13, we discussed general concepts in the field of cancer epidemiology, and in particular, methods to estimate effects of exposures on outcomes. Various types of models were introduced and discussed, especially logistic and logit-type models of tumor control and normal tissue complication probability. These concepts have broad applications across the fi eld of oncology, particularly for assessing dose–response effects of exposures on organs and tumors. Such models are critical for designing optimal therapeutic approaches and estimating the impact of new interventions. In this chapter, we consider the problem of adverse effects on long-term morbidity and toxicity. This is particularly apropos in the setting caused by unwanted radiation dose delivery to the heart. This is of particular concern in breast cancer, because many patients survive their cancer but are subject to potentially serious late effects of therapy. This scenario is common in what is known as the survivorship setting, which affects more than 10 million people annually in the United States living with the aftereffects of cancer treatment (1). Investigation of radiation heart dose also sheds light on the importance of recognizing that exposures are often not “all or nothing, ” the importance of accurate and precise measurement of the exposure, the importance of considering comorbid illness and competing events, and the pitfalls of investigating a treatment that is evolving faster than long-term evidence can be generated.

Original languageAmerican English
Title of host publicationPrinciples of Clinical Cancer Research
PublisherSpringer International Publishing
Pages254-263
Number of pages10
ISBN (Electronic)9781617052392
ISBN (Print)9781620700693
StatePublished - Nov 28 2018

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Survivorship: Effects of Cancer Treatment on Long-Term Morbidity'. Together they form a unique fingerprint.

Cite this